Skip to main content
SpringerLink
Log in

Tripeltherapie der COPD

Zahlt sich die Beschränkung auf einen Inhalator aus?

  • Journalclub
  • Published:
Pneumo News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Bryan Williams, Giuseppe Mancia, Wilko Spiering et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39(33):3021-104

  2. Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie COPD - Teilpublikation der Langfassung, 2. Auflage. Version 1. 2021. DOI: 10.6101/AZQ/000477. www.leitlinien.de/copd

  3. Alvar GA, Vogelmeier C et. al. Global initative for chronic obstructive lung disease, 2023 report. https://goldcopd.org/

  4. Cho EE, Gershon AS. Single vs Multiple Inhaler Triple Therapy in the COPD Population. Chest. 2022 Nov;162(5):94-8

  5. Haidl P, Siemon K, Mezrhab J. Probleme der Inhalation im Alter. Pneumologe. 2021;18:154-61

  6. Suissa S, Dell'Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012;67(11):957-63

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik und Poliklinik V, Klinikum der Universität München (LMU), Ziemssenstr. 5, 80336, München, Deutschland

    Thomas Melzer &  Kathrin Kahnert

Authors
  1. Thomas Melzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kathrin Kahnert
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Melzer, T., Kahnert, K. Zahlt sich die Beschränkung auf einen Inhalator aus?. Pneumo News 15, 14–15 (2023). https://doi.org/10.1007/s15033-022-3461-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-022-3461-5

Search

Navigation